This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Biogen Ma Inc., Samsung Bioepis. Active years: 2021-2025.
Company Filing History:
2 out of 267 
2 out of 5 Years Active: 2021-2025
Title: Eunchong Yang: Innovator in Cell Culture Technologies
Introduction
Eunchong Yang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in cell culture technologies. With a total of 2 patents, Yang's work focuses on overcoming challenges in mammalian cell culture.
Latest Patents
Yang's latest patents include innovative methods for overcoming glutamine deprivation during mammalian cell culture. The first patent pertains to methods of producing polypeptides of interest in cell cultures lacking glutamine. This invention further details a method of producing a protein of interest in large-scale cell culture by supplementing the culture with nucleic acid synthesis precursors and/or corticosteroids. The second patent is identical in focus, emphasizing the importance of addressing glutamine deprivation in cell cultures.
Career Highlights
Throughout his career, Eunchong Yang has worked with notable companies in the biotechnology sector. He has been associated with Biogen MA Inc. and Samsung Bioepis, where he has contributed to advancements in biopharmaceutical development.
Collaborations
Yang has collaborated with esteemed colleagues, including Jiuyi Lu and Hyoung Taek Lim, further enhancing his research and innovation efforts.
Conclusion
Eunchong Yang's contributions to biotechnology, particularly in cell culture technologies, highlight his role as an influential inventor. His patents reflect a commitment to solving critical challenges in the field, paving the way for future advancements.